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Discussion: Session 4*
New Approaches to Detecting
Low-Dose Effects
Dr. Radford began the discussion by asking Dr.
Christian if he could give a quick survey of the
types of environmental exposures that he believes
are most amenable to twin studies and give
examples.
Dr. Christian replied that he thought the major
use of this method is to control familial sources of
variation and try to get more efficient studies.
Evaluation of traits which are under more genetic
control, for example, would be very useful. A
recent survey oftwin studies of 11 different drugs
revealed that all had highly significant components
of genetic variance. This would be a fruitful area
to study. Another criterion is relatively short-term
effects, for example, his laboratory is trying to
determine the effects of salt on blood pressure. In
general, one can survey traits of interest just by
uniformity trials, to get an idea of how correlated
monozygotic twins are. He added that there have
not been a lot of studies of general environmental
agents by the twin method.
Dr. Radford commented that the twin registry
of the Veterans Administration has been around a
long time. One of the concerns of the people who
maintain the registry has been that the registry
will die out before anybody really uses it properly.
It may be as Dr. Christian pointed out, that
ascertaining the twin status in a study will be a
very useful adjunct to the study. On the other
hand, ifone is really going to use the twin method,
only by resorting to twin registries will the num-
bers be big enough. Otherwise, the twin sample
may not be sufficient to pick up the kinds of subtle
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effects that low-level exposures to environmental
agents may produce. He asked Dr. Christian
whether there ought to be a recommendation that
money be budgeted to set up a twin registry on a
continuing basis, as has been done, for example, in
Sweden. Dr. Christian commented that people
may not be aware of the World War II Veterans
twin registry. It is sponsored and kept track of by
the National Academy of Sciences and the Na-
tional Research Council. They have an Advisory
Committee on which he is serving at the present
time. There has indeed been concern that the
registry has been underutilized. These twins are
now 55 years of age on the average, with a range
of about 10 years of age, and the registry consists
of about 15,000 pairs of twins. He has reviewed
the status of all twin registries in the United
States and Canada and he thought there are about
31 panels available. Most of these are ascertained
because they are twins. To use these to look for
specific risk factors or specific diseases may result
in fairly low yield, even though some of the panels
are quite large. The largest twin panels in the
world are in the Scandinavian countries. This is
primarily because of their national health insur-
ance which allows them to keep track of people.
He had tried to stress, however, that another
resource had not been tapped, and that is the case
where twins are ascertained, not because they are
twins, but because they are from a relatively large
group of people who are at risk. He thought this
opportunity has really not be exploited. He and his
colleagues are doing a study on hypertension and
are trying to develop a twin panel ofthis type. He
believed the yield of twins at risk is likely to be
higher if one is studying several thousand individ-
uals who are at high risk from some sort of
environmental cause or disorder, than for twin
registries that are maintained because they are
twins. He also thought that bias of ascertainment
might be lower for twin subsets of a general
115population than for twin registries. He emphasized
that it is very easy to ascertain whether a person
is a twin or not, and therefore he urged those in
the audience to keep track of twins in their
studies.
Mr. David Goldsmith (Research Triangle Insti-
tute, North Carolina) asked Dr. Conner if there
was a possibility that some of the false positives
from sister chromatid exchange could result from
such heavy exposures that no cells would be
dividing. Secondly, could she given an estimate of
the proportion of false negatives that might be
found for sister chromatid exchange. He thought
this measure of validity was an important contri-
bution of the complete Ames test protocol. How-
ever, for other kinds of short-term assays there
has not been a well-organized attempt to deter-
mine the sensitivity and specificity ofthe tests.
Dr. Conner replied that with regard to false
positives, Mr. Goldsmith was correct in that with a
relatively high acute dose, if the agent is in fact
lethal to the cells, that would distort the popula-
tion that would be scored, since any cells that are
lost cannot be scored. But she thought that this
source of error could be detected, for example, by
doing a kinetic analysis at various times after
exposure. Laboratory tests ofdose-response to the
particular chemical are the best way to deal with
this problem.
With regard to negative results, one agent
which she had mentioned was radiation, which is
not very effective as a sister chromatid exchange
inducer. Agents such as bleomycin cause the same
basic damage as x-rays and are also not very
effective in the SCE assay. Concerning the rela-
tive sensitivity and specificity of the Ames test
and other tests, she considered that no matter
what mutagen assay test system was used, each
has its own specific sensitivity and specificity. She
thought these should be determined in terms of
the reaction of chemical groups, allowing one to
group chemicals according to structure-reactivity.
Dr. Philip Archer (University of Colorado Medi-
cal School) commented that he had been participat-
ing in the screening of workers for chromosomal
abnormalities for some time, and while they found
a radiation dose-response, he agreed with Dr.
Conner about the cost justification for this ap-
proach. It is very costly and probably is not
justified for other than research purposes or possi-
bly in cases of very heavy exposures. Their group
has cut back from 100 cells per person to about 30
cells and they have stockpiled the unread slides,
essentially establishing a potential data base for
possible future reference. He asked Dr. Conner to
comment on her allusion to an effect of age on
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frequency of chromosomal abnormalities. They
have not found such an effect in their control
groups. He also asked whether a new banding
technique, in which the cells are stopped at a
different part of the cycle, could be used as a
screening tool for detecting effects of environmen-
tal exposures.
Dr. Conner addressed the second question. She
thought the new technique is used primarily by
Yunis. She was not familiar with any application in
population screening, but she believed it may
appear to be more promising than it really might
be, because she thought it would be difficult to
obtain the proper cell population sizes with clear
chromosome elongation and banding patterns, al-
though the fact that one obtains more banding
patterns may give you more information concern-
ing a specific type of damage.
Dr. Neil Wald (University of Pittsburgh) re-
sponded to the question about the effect of age on
chromosome aberrations. In Evans' study of nu-
clear shipyard workers exposed to low radiation
doses, he demonstrated an effect ofage, but he did
not indicate whether he considers this effect could
be due to accumulation of background radiation
exposure which also increases with age. Another
factor could be medical diagnostic x-ray exposure
that also increases with age.
Dr. S. Raman (University of Ottawa) asked Dr.
Connerabouttheproblemofcomparative cytogenetic
results from different laboratories and the possible
reasons for differences found in controls. He also
commented that since some cytogenetic responses
are transient they can be modified by a number of
factors, such as smoking and drugs. In this case,
there may be little specificity of effects observed.
Dr. Conner replied that with regard to variation
among laboratories, some of the factors that she
had mentioned, such as smoking and other factors,
were not taken into consideration by all the
laboratories. But more importantly, she thought
the technique was still new enough that all of the
factors that contribute to increased exchange lev-
els have not been well defined. A recent paper has
suggested that the concentration of the BrDU
analog in the culture medium is more important in
inducing baseline SCE's than that incorporated
into the chromosomes. Some ofthe reasons for this
effect are going to have to be investigated further
before we can reduce the variability between labs.
The makeup of the cell culture medium may be
very critical. With regard to the specificity oftheir
techniques, she should have mentioned that in the
Livermore study, in particular, all of the individu-
als in the study population were extensively inter-
viewed to determine smoking habits, whether they
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diseases, and so forth. Those individuals who gave
a positive history were removed from both the
control and exposed populations before the final
comparison was done. She thought this was very
important, and these issues were going to have to
be addressed in order to remove possible con-
founding factors.
Dr. Gordon Newell (Assembly of Life Sciences,
National Research Council) commenting on the
reliability of data, stated that the Environmental
Mutagen Society is finally addressing this prob-
lem. He strongly urged that those employing these
short-term tests make sure the laboratory can
produce reliable and consistent results. He cited a
major study of 22 pairs of compounds that are
being evaluated blind by about 15 laboratories
using the Ames test. He thought that about 15% of
the compounds tested had results widely different
among the test laboratories. It is these kinds of
difficulties that give great concern to people when
new procedures come along. He hoped that some-
one will take the responsibility in a central
organization and distribute some unknowns on a
regular basis, as is done for clinical laboratories. A
procedure that might be worthwhile is called the
host-mediated assay in which, after exposure to a
known mutagen, urine is tested for breakdown
products and conjugates, and these are assayed for
mutagenicity. This technique has a fair amount of
reliability.
Dr. Joseph H. Meyer (E.R. Squibb & Sons,
Princeton, New Jersey) asked Dr. Petrakis to
speculate on the possible role ofgenetic interaction
with some drug effects that are postulated. For
example, the question of reserpine causing breast
cancer; vaginal cancer in daughters of mothers
who had estrogens during pregnancy; estrogen
and endometrial cancer or birth defects. Scientific
evidence on these issues comes from retrospective
studies which figure very prominently as legal
evidence. These retrospective studies have not
paid heed to possible genetic factors. He wondered
what role genetics, in hindsight, could play in
these situations. Dr. Petrakis replied that he had
mentioned pharmacogenetic studies. For example,
twin studies using pharmacogenetic approaches
have shown some things one could learn about
genetic-environmental interaction. At presentthese
matters are still largely speculative. The method
that Dr. Tokuhata showed and that he had also
used, may be a way to look at this question of
genetic-environmental interaction. He thought one
could look at any condition where there is familiality
and try to examine some of the factors ofinterest.
The problem here will be the need for sufficient
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numbers in each of the groups to enable one to do
a good epidemiological analysis. Dr. Christian
commented that among all ofthe drugs that he had
looked at, there was a spectrum of genetic vari-
ability among people studied, not only affecting
toxicity but also effectiveness. Some people genet-
ically are such that they do not respond as one
might expect them to. Many studies ofthis type of
relationship are retrospective and prospective stud-
ies will be helpful. When Dr. Schneiderman was
talking yesterday about needing 20 years of expo-
sure and 20 years of follow-up for his work, we
may need to follow these patients and their de-
scendents for five generations!
Dr. Turner stated that for epidemiologists the
attractiveness of monozygotic (MZ) twins in a
study is very great. However, there are aspects of
the biology oftwinning which suggest that caution
should be applied to generalizing from studies of
twins because of developmental differences be-
tween MZ twins which can be substantial. Thus
studies which define increased risks between mon-
ozygotic twins, in an epidemiologic sense, may be
primarily relatable to embryogenesis of the twins.
Many geneticists tend to think that MZ twins are
superior instruments for study when in fact they
are not. The question is: to what degree does the
lateralization of the developmental process of the
MZ twin interfere with or weaken inferences, as one
would draw them, when one compares twins with
paired members from the nontwin population.
Dr. Christian agreed that this is a major prob-
lem. In classic twin studies, when we compare the
two types of twins and the trait itself may be
associated with one twin or the other, for those
associated with the MZ twins there may be
lateralization effects. One striking example is that
there are more left-handed twins than there are
left-handed singletons, and left-handed twins are
most likely the psychologically dominant twin. A
recent study from his laboratory, published with
all sorts of disclaimers, showed that in pairs of
identical twins in which there was a left-handed
and a right-handed twin, the left-handed one was
born first 80% of the time. A Finnish twin panel
found the same result. What it means in terms of
twin studies is unclear. For the type of studies he
had discussed, lateralization is not particularly
important because there is a built-in measure of
the concordance or the similarity of these twins.
That is why he emphasized that to study any trait
one should first see how similar these twins are,
and if one finds MZ twins are markedly different
for one reason or another, then the study might
teach something about twins, but it is not likely to
tell much about the drug.
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